Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Search
No matching results for ''
Tip: Try a valid symbol or a specific company name for relevant results
Mail
Finance Home
News
Market Data
Crypto
IPO Watch
Personal Finance
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets open in 2 hours 50 minutes
NIKKEI 225
26,718.66
+40.86
(+0.15%)
HANG SENG
20,126.34
-44.93
(-0.22%)
CRUDE OIL
110.96
+0.63
(+0.57%)
GOLD FUTURES
1,848.70
+2.40
(+0.13%)
DOW
32,120.28
+191.66
(+0.60%)
BTC-GBP
23,673.97
-349.66
(-1.46%)
Money
How to survive and thrive during a cost of living crisis
Top tips on managing the cost everyday life from groceries to holidays
Cyteir Therapeutics, Inc. (CYT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.8700
0.0000
(0.00%)
At close: 04:00PM EDT
1.8700
0.00
(0.00%)
After hours:
04:00PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
Operating expenses
Research development
35,434
30,959
16,765
12,768
Selling general and administrative
13,619
11,300
4,178
3,345
Total operating expenses
49,053
42,259
20,943
16,105
Operating income or loss
-49,053
-42,259
-20,943
-16,105
Total other income/expenses net
137
133
120
1,061
Income before tax
-48,916
-42,126
-20,823
-15,044
Income from continuing operations
-48,916
-42,126
-20,823
-15,044
Net income
-48,916
-42,126
-20,823
-15,044
Net income available to common shareholders
-48,916
-42,126
-20,823
-15,044
Basic EPS
-
-
-1.07
-0.77
Diluted EPS
-
-
-1.07
-0.77
Basic average shares
-
-
19,434
19,434
Diluted average shares
-
-
19,434
19,434
EBITDA
-
-41,780
-20,592
-15,890
© 2022 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Privacy Dashboard
Privacy (updated)
About our ads
Terms (updated)